Image 1 caroussel

Mini-Symposium - Residual Disease in Cancer - 30 septembre 2021

Séminaire/ Congrès GSO

A lieu le 30 septembre 2021 à partir de 14h00
jusqu'au 30 septembre 2021 à 18h00

  • Lieu : Virtual
  • Organisateur : Cancéropôle GSO Axis 1 "Cell signaling and therapeutic targets"

Description

Invited speakers

Jean-Christophe MARINE, VIB-KU Leuven, Belgium "Nongenetic mechanisms of drug tolerance and resistance in melanoma"

Craig JORDAN, University of Colorado Anschutz Medical Campus, USA "Metabolic vulnerabilities of leukemia stem cells"

Christoph KLEIN, Experimental Medicine and Therapy Research; University of Regensburg, Germany "Identification and molecular characterization of the earliest metastasis founder cells in melanoma"

Jean-Emmanuel SARRY, Cancer Research Center of Toulouse "Metabolic drivers of residual disease in acute myeloid leukemia"

Julie PANNEQUIN (IGF, Montpellier) "Role of translational control in the colorectal cancer cell plasticity in response to 5-FU"

Cathy SAWAI, Inserm U1218, Bordeaux, "A novel model to study the in vivo functions of normal hematopoietic and leukemic stem cells during chronic myeloid leukemia"

 

DETAILED PROGRAM>>

Call for abstracts

A call for abstracts is opened to the GSO community until September 12th. Click here to submit online>>

 

CLICK HERE TO JOIN THE ZOOM MEETING>>  or https://umontpellier-fr.zoom.us/j/86361158504

ScienceDirect.com

Export iCal microformat: hcalendar

Retour au calendrier